Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
A primary or metastatic malignant neoplasm that affects the duodenum. Representative examples include carcinoma, lymphoma, and sarcoma.
Biomarker and diagnostic research for duodenum cancer has been reported in the published literature.
10 clinical trials registered, 3 recruiting. Interventions under study include procedural interventions, other interventions, and drug therapy. Pipeline includes 1 PHASE3, 1 PHASE2, 1 PHASE1. Research is primarily sponsored by academic and government institutions.
NCT ID | Title | Phase | Sponsor | Status |
|---|---|---|---|---|
[NCT07199127](https://clinicaltrials.gov/study/NCT07199127) |
Data assembled from 3 of 12 sources · Last updated Sep 18, 2026, 10:20 PM UTC
Duodenal Polyposis Classification in FAP |
— |
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano |
RECRUITING |
[NCT06411795](https://clinicaltrials.gov/study/NCT06411795) | Rectus Sheath Block With Liposomal Bupivacaine Versus Thoracic Epidural Analgesia for Pain Control Following Pancreatoduodenectomy | PHASE2 | Masonic Cancer Center, University of Minnesota | RECRUITING |
[NCT02012699](https://clinicaltrials.gov/study/NCT02012699) | Integrated Cancer Repository for Cancer Research | — | University of Nebraska | RECRUITING |
203 publications have been identified in PubMed for duodenum cancer. Research spans Clinical Trial Publication (22%), Case Report / Case Series (21%), and Review / Meta-Analysis (18%).
Research Type | Count | % of Total |
|---|---|---|
Clinical study results | 44 | 22% |
Patient case studies | 43 | 21% |
Research summaries | 36 | 18% |
Disease patterns and progression | 33 | 16% |
Laboratory research | 29 | 14% |
Testing and diagnosis research | 13 | 6% |
New treatment approaches | 3 | 1% |
Other research | 2 | 1% |
Vu Trung K (2026). [PMID: 40550486](https://pubmed.ncbi.nlm.nih.gov/40550486/). *Endoscopy*. [Clinical Trial Publication]
Arends MJ (2026). [PMID: 41724188](https://pubmed.ncbi.nlm.nih.gov/41724188/). *Histopathology*. [Review / Meta-Analysis]
Tjandra D (2026). [PMID: 42029141](https://pubmed.ncbi.nlm.nih.gov/42029141/). *J Clin Gastroenterol*. [Other]
Sheth S (2026). [PMID: 42181493](https://pubmed.ncbi.nlm.nih.gov/42181493/). *Cureus*. [Case Report / Case Series]
Hendren JR (2026). [PMID: 41494143](https://pubmed.ncbi.nlm.nih.gov/41494143/). *JCO oncology practice*. [Basic Science / Preclinical]
de Pretis N (2026). [PMID: 40530519](https://pubmed.ncbi.nlm.nih.gov/40530519/). *European journal of gastroenterology & hepatology*. [Basic Science / Preclinical]
Charifa A (2026). [PMID: 29493967](https://pubmed.ncbi.nlm.nih.gov/29493967/). *Unknown Journal*. [Basic Science / Preclinical]
AbdullGaffar B (2026). [PMID: 41056600](https://pubmed.ncbi.nlm.nih.gov/41056600/). *Annals of diagnostic pathology*. [Review / Meta-Analysis]
Shiraishi T (2026). [PMID: 41799599](https://pubmed.ncbi.nlm.nih.gov/41799599/). *Annals of gastroenterological surgery*. [Diagnostic / Biomarker]
Duan R (2026). [PMID: 41358844](https://pubmed.ncbi.nlm.nih.gov/41358844/). *Clinical nuclear medicine*. [Diagnostic / Biomarker]